This inventor holds 1 USPTO granted patent. Top assignee: Meiji Seika Kaisha, Ltd.. Active years: 1980.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1980
Title: Kunikazu Totsugawa: Innovator in Antibiotic Development
Introduction
Kunikazu Totsugawa is a prominent inventor based in Tokyo, Japan. He is known for his significant contributions to the field of antibiotics, particularly through his innovative work on new antibiotic substances.
Latest Patents
Totsugawa holds a patent for the antibiotics SF-2050 and SF-2050B. These substances are produced by cultivating a microorganism, Streptomyces sp. SF-2050, which is now deposited under FERM-P 4358 and ATCC 31450. The antibiotics are cultivated in a liquid culture medium under aerobic conditions. They can be isolated from the fermentation broth and are useful as antibacterial agents. Notably, these antibiotics exhibit activity that inhibits β-lactamase.
Career Highlights
Kunikazu Totsugawa is associated with Meiji Seika Kaisha, Ltd., where he has made significant strides in antibiotic research and development. His work has contributed to advancements in the pharmaceutical industry, particularly in the creation of effective antibacterial agents.
Collaborations
Totsugawa has collaborated with notable colleagues, including Kazunori Ohba and Chuhei Nojiri. Their combined efforts have furthered research in the field of antibiotics and enhanced the understanding of microbial cultivation techniques.
Conclusion
Kunikazu Totsugawa's innovative work in developing new antibiotics has made a lasting impact on the field of medicine. His contributions continue to influence antibiotic research and development, showcasing the importance of innovation in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile